RecruitingNot ApplicableNCT07176949

Early-Onset Myopia Intervention Project

Project on Myopia Surveillance and Intervention Services for Preschool Children in Shanghai


Sponsor

Shanghai Eye Disease Prevention and Treatment Center

Enrollment

508 participants

Start Date

Jun 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The prevalence of myopia among children has been increasing year by year, which has become a globle public health issue. Studies have shown that defocusing lenses and atroping eyedrops can control the progression of myopia, but there is little evidence of its efficacy in myopia intervention of young pre-schoolers who will face a greater risk of progression to high myopia later in life. Therefore, this study aims to evaluate the effectiveness and safety of spectacle lenses with highly aspherical lenslets (Essilor's Stellest) , as well as 0.01% and 0.05% low concentration atropine eyedrops in myopia intervention among young children aged 3-6.


Eligibility

Min Age: 3 YearsMax Age: 6 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called 0.01% atropine eye drops, a drug called 0.05% atropine eye drops, and others for people with myopia and pre-myopia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 3 Years to 6 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUG0.01% atropine eye drops

Participants will use 0.01% atropine eyedrops nightly for myopia control.

DRUG0.05% atropine eye drops

Participants will use 0.05% atropine eyedrops nightly for myopia control.

DEVICESpectacle lenses with highly aspherical lenslets

These are a special type of eyeglass lenses designed primarily to slow down the progression of myopia (nearsightedness) in children. The center of the lens provides a clear correction for distance vision, just like regular glasses. The surrounding area contains hundreds of tiny, invisible, and highly aspherical (complex curved) microlenses. These microlenses create a special optical effect. While the child looks straight ahead clearly, peripheral light rays are focused in front of the retina. This is called "myopic defocus." Research suggests that this myopic defocus signal helps to control the excessive elongation of the eyeball, which is the main cause of myopia getting worse.


Locations(1)

Shanghai Eye Disease Prevention and Treatment Center

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07176949


Related Trials